ANXA2 is also one of the potential biomarkers for LN because its level correlates with the LN status (Ka et al., 2006; Salle et al., 2016; Cheung et al., 2017; Zhou et al., 2018). This evidence concerns the gene ANXA2 and lobular neoplasia.